While α-synuclein pathology in cortical areas does lead to cognitive dysfunction in mice overexpressing mutant α-synuclein or those injected with PFFs47, our study specifically challenges the necessity of α-synuclein pathology in the development of cognitive deficits in GBA mutations. The gene discussed is SNCA; the disease is Cognitive impairment.